Katia Schlienger's most recent trade in Hookipa Pharma Inc was a trade of 184,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hookipa Pharma Inc | Katia Schlienger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 184,000 | 184,000 | - | - | Stock Option (Right to Buy) |